SEC Form 4 · accession 0001140361-18-029730
NRC HEALTH · NRC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jun 21, 2018
Accepted (ET)
Jun 25, 2018 · 1:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000070487
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 21, 2018 | S | 2,548 | $38.0957 | D | 5,748,974 | D | |
| Common Stock | Jun 22, 2018 | S | 2,893 | $38.00 | D | 5,746,081 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2018.
- F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.00 to $38.25, inclusive. The Reporting Person undertakes to provide National Research Corp. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Remarks
This Form 4 is being filed by the K/I/E/Trust Under Agreement 3/9/09, f/k/a Michael and Karen Hays Grandchildren's Trust Dated March 9, 2009, and by Kent E. Endacott, as Special Holdings Direction Adviser under the K/I/E/Trust Under Agreement 3/9/09.